Lithium succinate

Lithium succinate (C₄H₅Li0₄), the lithium salt of succinic acid, is a drug used in the treatment of seborrhoeic dermatitis[1] and proposed for the treatment of anogenital warts.[2]

Lithium succinate

Clinical data
AHFS/Drugs.com	Monograph
ATC code	D11AX04 (WHO)
Identifiers
IUPAC name lithium butanedioic acid
PubChem CID	10197702
ChemSpider	8373202^Y
ECHA InfoCard	100.163.153
Chemical and physical data
Formula	C4H5LiO4
Molar mass	124.02 g·mol^−1
3D model (JSmol)	Interactive image
SMILES [Li+].[Li+].[O-]C(=O)CCC([O-])=O
InChI InChI=1S/C4H6O4.2Li/c5-3(6)1-2-4(7)8;;/h1-2H2,(H,5,6)(H,7,8);;/q;2*+1/p-2^Y Key:WAHQBNXSPALNEA-UHFFFAOYSA-L^Y
(verify)

References

1. Leeming JP (1993). "Use of topical lithium succinate in the treatment of seborrhoeic dermatitis". Dermatology. 187 (2): 149–50. doi:10.1159/000247228. PMID 8358107.
2. Ward KA, Armstrong KD, Maw RD, Winther MD, Gilburt SJ, Dinsmore WW (1997). "A pilot study to investigate the treatment of anogenital warts with Topical Lithium Succinate cream (8% lithium succinate, 0.05% zinc sulphate)". International Journal of STD & AIDS. 8 (8): 515–7. doi:10.1258/0956462971920677. PMID 9259500.